Stay updated on OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision label in the site footer updated from v3.3.1 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-01T16:38:24.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.1; removed the older PubMed-sourced sentence and the Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T11:57:33.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Deleted the government funding/operating status notice that used to appear at the bottom of the page. The notice described potential delays in updates and NIH facility operations.
    Difference
    0.4%
    Check dated 2025-11-17T06:18:43.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    External links to PubMed and U.S. government sites were removed from the page footer. The core study details and page structure remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-03T00:57:26.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now includes new external references, including a PubMed publication (40598566), and links to government sites such as HHS, NIH, NLM, NCBI, and USA.gov. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-26T20:30:13.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Updated system to revision v3.2.0 and added a government operating status notice; removed the previous No Results Posted and v3.1.0 references.
    Difference
    4%
    Check dated 2025-10-05T08:35:07.000Z thumbnail image

Stay in the know with updates to OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OP-1250 Dose Escalation/Expansion in HR+, HER2- Breast Cancer Clinical Trial page.